Interacting with Anusha Ashwin of BioSpectrum, Sridharan Mani, CEO and Director of American Megatrends India Pvt Ltd (AMI), outlines the growing trend of mobility solutions in healthcare and the company's products and services
Could you please give a brief introduction about American Megatrends India Pvt Ltd and its business in healthcare solutions?
American Megatrends India Pvt Ltd (AMI) is a leader in high-tech engineering and computing innovations worldwide. AMI has more than 200 patents awarded globally on innovative engineering solutions and AMI products are shipping in more than half a billion of computers in the world today. AMI are specialty leaders in embedded services, BIOS customization and porting, mobility solutions, IP SAN/NAS Data storage solutions, Infrastructure Asset Management, Telematics Solutions, Knowledge Management System, Healthcare IT solutions, Platform Validation Services and Android Services.
At AMI, we promote 'Prevention is better than Cure' and we firmly believe in it. Our healthcare products and services are designed to bring awareness of individual's health to palm of their hands. Our lifestyle products AMI B.O.L.T and AMI VitalsFit are designed to address these requirements by supporting individuals to measure the key health parameters in comfort of their homes. The ability to maintain trends and share the health records instantaneously with quality healthcare providers makes our solution unique and first of its kind.
AMI's VitalsFit is the only Indian entrant for the Qualcomm Tricorder XPRIZE, which is quite an accomplishment. How was this planned and achieved?
Even before we came to know of this competition, AMI had an internal team working on a solution similar to this to meet the key supply-demand challenges of the current healthcare system. Currently, telemedicine systems are restricted to video conferencing facility between patients and care givers. It does not address the importance of sharing key health parameters with care providers. Also, the healthcare is more oriented towards cure and symptom-based diagnosis than prevention.